Real-time enrollment status for this carcinoma, non-small cell lung clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:53 PM UTC
| NCT Number | NCT04389632 |
| Recruiting Status | Recruiting |
| Condition | Carcinoma, Non-Small Cell Lung |
| Phase | PHASE1 |
| Target Enrollment | 1,006 participants |
| Active Locations | 106 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of August 27, 2026: Clinical trial NCT04389632 is currently recruiting participants. This phase1 study for carcinoma, non-small cell lung is actively seeking new participants at 106 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04389632 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 106 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04389632 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.